Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action lawsuit against Intellia Therapeutics, Inc. (NASDAQ: NTLA) for alleged securities fraud affecting investors between July 30, 2024, and January 8, 2025.
March 18, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities fraud, potentially impacting its stock price negatively in the short term.
The announcement of a class action lawsuit for alleged securities fraud is likely to negatively impact investor sentiment and the stock price of Intellia Therapeutics in the short term. Legal issues can lead to uncertainty and potential financial liabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100